Lockheed Martin Total Cost of Revenue decreased by 11.4% to $15.94B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.9%, from $15.64B to $15.94B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 3.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $14.88B | $13.73B | $15.31B | $13.06B | $13.49B | $14.46B | $16.69B | $13.08B | $14.60B | $14.83B | $16.58B | $15.20B | $15.99B | $14.99B | $17.93B | $15.64B | $17.42B | $16.37B | $18.00B | $15.94B |
| QoQ Change | — | -7.7% | +11.5% | -14.7% | +3.3% | +7.2% | +15.4% | -21.6% | +11.6% | +1.6% | +11.8% | -8.3% | +5.2% | -6.3% | +19.7% | -12.8% | +11.4% | -6.0% | +10.0% | -11.4% |
| YoY Change | — | — | — | — | -9.3% | +5.4% | +9.0% | +0.2% | +8.3% | +2.5% | -0.7% | +16.2% | +9.5% | +1.1% | +8.2% | +2.9% | +8.9% | +9.2% | +0.4% | +1.9% |
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Aeronautics | $6.34B | $7.52B | $6.57B | $7.74B | $6.33B |
| RMS | $3.86B | $4.17B | $3.87B | $4.15B | $3.56B |
| MFC | $2.91B | $2.96B | $3.11B | $3.48B | $3.15B |
| Space | $2.82B | $2.96B | $3.03B | — | $3.14B |
| Total | $15.64B | $17.42B | $16.37B | $18.00B | $15.94B |